| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $93K | -34.0% | -21.2% |
| SG&A Expense | $2.0M | +64.0% | +739.7% |
| Operating Income | -$2.1M | -53.9% | -120.6% |
| Net Income | $747K | +110.1% | +124.5% |
| EPS (Basic) | -$0.17 | +86.3% | +61.4% |
| EPS (Diluted) | -$0.17 | +86.3% | +61.4% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.2M | +30.9% | +23.1% |
| Short-term Investments | $372K | +85.0% | -0.1% |
| Current Assets | $20.7M | -10.1% | +22.0% |
| Total Assets | $55.9M | -0.2% | +27.5% |
| Current Liabilities | $1.7M | +6.4% | +40.5% |
| Total Liabilities | $16.5M |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | — |
| Investing Cash Flow | $2.0M | — | — |
| Financing Cash Flow | $6.8M | — | — |
| +360.3% |
| Stockholders' Equity | $38.1M | +8.2% | -5.3% |